|
End-of-day quote
Shenzhen S.E.
2026-10-29
|
5-day change | 1st Jan Change | ||
| 134.21 CNY | -1.50% |
|
-11.84% | +44.42% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 47,015 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 44.19% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 43,501 | 44,196 | 45,090 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 65.17% | 1.6% | 2.02% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 36.4x | 27.3x | 21.1x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 2.59x | 2.42x | 2.23x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 2.2x | 0.8x | 0.7x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 5.82x | 4.74x | 3.87x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 5.38x | 4.46x | 3.72x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 21.3x | 17x | 14x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 28.8x | 22.2x | 18.2x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -45.6x | -585x | 64x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -2.19% | -0.17% | 1.56% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.282 | 1.803 | 2.151 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.96% | 1.34% | 1.6% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.684 | 4.92 | 6.371 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 34.8% | 36.6% | 33.8% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,080 | 9,916 | 12,135 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,043 | 2,600 | 3,226 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,511 | 1,995 | 2,484 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,325 | 1,775 | 2,298 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -3,514 | -2,819 | -1,925 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 134.21 | 134.21 | 134.21 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.99x | 5.48x | 21.68x | 0.94% | 7.17B | |
| 37.84x | 13.27x | 28.43x | 0.53% | 1,148B | |
| 39.67x | 6.67x | 18.75x | 1.97% | 652B | |
| 37.4x | 8.39x | 17.35x | 2.4% | 505B | |
| 21.45x | 5.21x | 12.93x | 2.51% | 384B | |
| 102.73x | 5.76x | 24.72x | 2.42% | 348B | |
| 21.89x | 5.76x | 13.88x | 2.85% | 294B | |
| 22.21x | 4.49x | 12.82x | 1.97% | 264B | |
| 28.66x | 7.33x | 13.12x | 2.23% | 244B | |
| -45.79x | 7.11x | 27.55x | 2.07% | 197B | |
| Average | 30.31x | 6.95x | 19.12x | 1.99% | 404.43B | |
| Weighted average by Cap. | 35.29x | 8.39x | 20.64x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
